India’s Lambda Therapeutic Research Buys Canada’s Biovail Corporation’s CRO Division

outsourcing-pharma.com -- Contract research organization (CRO) Lambda Therapeutic Research has acquired Biovail’s contract research division. The unit, which has been renamed Lambda Canada, extends the Indian CRO’s global reach, adding a 46,000 sqft site in Toronto, Canada to its network of research units in Poland and the UK and its office in the US.

MORE ON THIS TOPIC